PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,236,372 | -32.1% | 74,123 | +12.5% | 0.00% | 0.0% |
| Q2 2023 | $1,819,937 | +76.4% | 65,892 | +46.9% | 0.00% | 0.0% |
| Q1 2023 | $1,031,665 | +410.6% | 44,855 | +142.2% | 0.00% | – |
| Q4 2022 | $202,031 | +29.0% | 18,518 | -0.3% | 0.00% | – |
| Q3 2022 | $156,562 | +2.1% | 18,572 | -4.2% | 0.00% | – |
| Q2 2022 | $153,359 | -84.0% | 19,388 | -52.0% | 0.00% | -100.0% |
| Q1 2022 | $961,328 | +23.1% | 40,375 | +76.9% | 0.00% | – |
| Q4 2021 | $781,000 | +86.8% | 22,822 | -3.2% | 0.00% | – |
| Q3 2021 | $418,000 | -59.5% | 23,581 | +2.4% | 0.00% | -100.0% |
| Q2 2021 | $1,033,000 | +99.0% | 23,025 | +14.9% | 0.00% | – |
| Q1 2021 | $519,000 | +35.5% | 20,039 | +5.4% | 0.00% | – |
| Q4 2020 | $383,000 | +14.0% | 19,015 | +10.8% | 0.00% | – |
| Q3 2020 | $336,000 | +41.2% | 17,165 | +25.5% | 0.00% | – |
| Q2 2020 | $238,000 | +176.7% | 13,675 | +12.1% | 0.00% | – |
| Q1 2020 | $86,000 | +8.9% | 12,200 | +9.0% | 0.00% | – |
| Q4 2019 | $79,000 | -45.1% | 11,195 | +1.9% | 0.00% | – |
| Q3 2019 | $144,000 | +9.9% | 10,985 | +1.4% | 0.00% | – |
| Q2 2019 | $131,000 | +3175.0% | 10,836 | +1765.1% | 0.00% | – |
| Q2 2018 | $4,000 | -94.9% | 581 | -93.6% | 0.00% | – |
| Q1 2018 | $78,000 | -60.2% | 9,118 | -3.2% | 0.00% | – |
| Q4 2017 | $196,000 | +24.1% | 9,423 | +6.0% | 0.00% | – |
| Q3 2017 | $158,000 | +1115.4% | 8,886 | +697.7% | 0.00% | – |
| Q2 2017 | $13,000 | -86.0% | 1,114 | -84.6% | 0.00% | – |
| Q1 2017 | $93,000 | -26.2% | 7,227 | +25.8% | 0.00% | – |
| Q4 2016 | $126,000 | – | 5,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |